Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The G-rich Repeats in FMR1 and C9orf72 Loci Are Hotspots for Local Unpairing of DNA.

Abu Diab M, Mor-Shaked H, Cohen E, Cohen-Hadad Y, Ram O, Epsztejn-Litman S, Eiges R.

Genetics. 2018 Dec;210(4):1239-1252. doi: 10.1534/genetics.118.301672. Epub 2018 Nov 5.

PMID:
30396881
2.

Incomplete methylation of a germ cell tumor (Seminoma) in a Prader-Willi male.

Eldar-Geva T, Gross-Tsur V, Hirsch HJ, Altarescu G, Segal R, Zeligson S, Golomb E, Epsztejn-Litman S, Eiges R.

Mol Genet Genomic Med. 2018 Sep;6(5):811-818. doi: 10.1002/mgg3.448. Epub 2018 Jul 12.

3.

Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells.

Cohen-Hadad Y, Altarescu G, Eldar-Geva T, Levi-Lahad E, Zhang M, Rogaeva E, Gotkine M, Bartok O, Ashwal-Fluss R, Kadener S, Epsztejn-Litman S, Eiges R.

Stem Cell Reports. 2016 Nov 8;7(5):927-940. doi: 10.1016/j.stemcr.2016.09.011. Epub 2016 Oct 20.

4.

Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis.

Epsztejn-Litman S, Cohen-Hadad Y, Aharoni S, Altarescu G, Renbaum P, Levy-Lahad E, Schonberger O, Eldar-Geva T, Zeligson S, Eiges R.

PLoS One. 2015 Oct 16;10(10):e0138893. doi: 10.1371/journal.pone.0138893. eCollection 2015.

5.

Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells.

Yanovsky-Dagan S, Avitzour M, Altarescu G, Renbaum P, Eldar-Geva T, Schonberger O, Mitrani-Rosenbaum S, Levy-Lahad E, Birnbaum RY, Gepstein L, Epsztejn-Litman S, Eiges R.

Stem Cell Reports. 2015 Aug 11;5(2):221-31. doi: 10.1016/j.stemcr.2015.06.003. Epub 2015 Jul 16.

6.

FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells.

Avitzour M, Mor-Shaked H, Yanovsky-Dagan S, Aharoni S, Altarescu G, Renbaum P, Eldar-Geva T, Schonberger O, Levy-Lahad E, Epsztejn-Litman S, Eiges R.

Stem Cell Reports. 2014 Nov 11;3(5):699-706. doi: 10.1016/j.stemcr.2014.09.001. Epub 2014 Oct 3.

7.

Prevention of lysosomal storage diseases and derivation of mutant stem cell lines by preimplantation genetic diagnosis.

Altarescu G, Beeri R, Eiges R, Epsztejn-Litman S, Eldar-Geva T, Elstein D, Zimran A, Margalioth EJ, Levy-Lahad E, Renbaum P.

Mol Biol Int. 2012;2012:797342. doi: 10.1155/2012/797342. Epub 2012 Dec 26.

8.

Preventing mucopolysaccharidosis type II (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line.

Altarescu G, Renbaum P, Eldar-Geva T, Brooks B, Varshaver I, Avitzour M, Margalioth EJ, Levy-Lahad E, Elstein D, Epsztejn-Litman S, Eiges R.

Prenat Diagn. 2011 Sep;31(9):853-60. doi: 10.1002/pd.2786. Epub 2011 Jun 27.

PMID:
21706504
9.

Female sex bias in human embryonic stem cell lines.

Ben-Yosef D, Amit A, Malcov M, Frumkin T, Ben-Yehudah A, Eldar I, Mey-Raz N, Azem F, Altarescu G, Renbaum P, Beeri R, Varshaver I, Eldar-Geva T, Epsztejn-Litman S, Levy-Lahad E, Eiges R.

Stem Cells Dev. 2012 Feb 10;21(3):363-72. doi: 10.1089/scd.2011.0102. Epub 2011 Jun 24.

10.

Genetic manipulation of human embryonic stem cells.

Epsztejn-Litman S, Eiges R.

Methods Mol Biol. 2010;584:387-411. doi: 10.1007/978-1-60761-369-5_21.

PMID:
19907989
11.

De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes.

Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H, Bergman Y.

Nat Struct Mol Biol. 2008 Nov;15(11):1176-1183. doi: 10.1038/nsmb.1476. Epub 2008 Oct 26.

Supplemental Content

Loading ...
Support Center